New Tuberculosis Drug Trial Begins in South Africa
Tuesday, December 11, 2012 - 07:00
in Health & Medicine
Case Western Reserve University School of Medicine and AstraZeneca, a global biopharmaceutical company, today announced the first patient enrolled in a Phase 2a trial to assess the effectiveness of AZD5847, a new test drug for patients with tuberculosis, including patients with HIV co-infection.